Skip to main content
Erschienen in: Indian Journal of Pediatrics 7/2013

01.07.2013 | Original Article

Clinical and Etiological Profile of Refractory Rickets from Western India

verfasst von: Rajesh R. Joshi, Shailesh Patil, Sudha Rao

Erschienen in: Indian Journal of Pediatrics | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

To present clinical and etiological profile of refractory rickets from Mumbai.

Methods

Case records of 36 patients presenting over 2½ y with refractory rickets were evaluated with respect to clinical presentation, biochemical, radiological features and where needed, ophthalmological examination, ultrasonography and special tests on blood and urine.

Results

Twenty three (63 %) patients had renal tubular acidosis (RTA)—distal RTA in 20 and proximal RTA in 3 patients; 5 (14 %) had vitamin D dependent rickets (VDDR I in 2 and VDDR II in 3 patients), 4 (11 %) had chronic renal failure (CRF) and 2 each (6 %) had hypophosphatemic rickets and chronic liver disease as cause of refractory rickets. A significant proportion of patients with RTA and VDDR showed skeletal changes of rickets in the first 2 y of life, while those with hypophosphatemic rickets presented later. Patients with hypophosphatemic rickets had predominant involvement of lower limbs, normal blood calcium and PTH levels and phosphorus leak in urine. All patients with RTA presented with failure to thrive, polyuria and marked rickets; blood alkaline phosphatase levels being normal in almost 50 % patients. Three (75 %) patients with rickets due to CRF had GFR < 30 ml/min/1.73 m2 and hyperphosphatemia. Patients with cirrhosis due to biliary atresia had rickets inspite of taking high dose of vitamin D orally.

Conclusions

Refractory rickets is a disorder of multiple etiologies; a good history and clinical examination supplemented with appropriate investigations helps to determine its cause.
Literatur
1.
Zurück zum Zitat Grzanka K, Kucharz EJ. Vitamin D-resistant rickets. Wiad Lek. 2004;57:663–71.PubMed Grzanka K, Kucharz EJ. Vitamin D-resistant rickets. Wiad Lek. 2004;57:663–71.PubMed
2.
Zurück zum Zitat Gulati A, Paul V. Vitamin D. In: Ghai OP, Paul VK, Bagga A, eds. Essential pediatrics. 7th ed. New Delhi: CBS Publishers; 2010. pp. 80–4. Gulati A, Paul V. Vitamin D. In: Ghai OP, Paul VK, Bagga A, eds. Essential pediatrics. 7th ed. New Delhi: CBS Publishers; 2010. pp. 80–4.
3.
Zurück zum Zitat Zargar AH, Laway BA, Masoodi SR, et al. Hereditary hypophosphatemic rickets: report of a family from the Indian subcontinent. Postgrad Med J. 1999;75:485–7.PubMed Zargar AH, Laway BA, Masoodi SR, et al. Hereditary hypophosphatemic rickets: report of a family from the Indian subcontinent. Postgrad Med J. 1999;75:485–7.PubMed
4.
Zurück zum Zitat Beck-Nielsen SS, Brock-Jacobson B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and heriditary rickets in Southern Denmark. Eur J Endocrinol. 2009;160:491–7.PubMedCrossRef Beck-Nielsen SS, Brock-Jacobson B, Gram J, Brixen K, Jensen TK. Incidence and prevalence of nutritional and heriditary rickets in Southern Denmark. Eur J Endocrinol. 2009;160:491–7.PubMedCrossRef
5.
Zurück zum Zitat Adedoyin O, Gottlieb B, Frank R, et al. Evaluation of failure to thrive: diagnostic yields of testing for renal tubular acidosis. Pediatrics. 2003;112:e 463.CrossRef Adedoyin O, Gottlieb B, Frank R, et al. Evaluation of failure to thrive: diagnostic yields of testing for renal tubular acidosis. Pediatrics. 2003;112:e 463.CrossRef
6.
Zurück zum Zitat Sreedharan R, Avner ED. Renal tubular acidosis. In: Kliegman RM, Stanton BF, Joseph W, Schor N, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders; 2012. pp. 1808–11. Sreedharan R, Avner ED. Renal tubular acidosis. In: Kliegman RM, Stanton BF, Joseph W, Schor N, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders; 2012. pp. 1808–11.
7.
Zurück zum Zitat Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med. 1982;307:217–21.PubMedCrossRef Brenner RJ, Spring DB, Sebastian A, et al. Incidence of radiographically evident bone disease, nephrocalcinosis and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med. 1982;307:217–21.PubMedCrossRef
8.
Zurück zum Zitat Chesney RW, Kaplan BS, Phelps M, DeLuca HF. Renal tubular acidosis does not alter circulating values of calcitriol. J Pediatr. 1984;104:51–5.PubMedCrossRef Chesney RW, Kaplan BS, Phelps M, DeLuca HF. Renal tubular acidosis does not alter circulating values of calcitriol. J Pediatr. 1984;104:51–5.PubMedCrossRef
9.
Zurück zum Zitat Cunnhingham J, Fraher LJ, Revell PA, Papappoulos SE. Chronic acidosis with metabolic bone disease—effect of alkali on bone morphology and vitamin D metabolism. Am J Med. 1982;73:199–204.CrossRef Cunnhingham J, Fraher LJ, Revell PA, Papappoulos SE. Chronic acidosis with metabolic bone disease—effect of alkali on bone morphology and vitamin D metabolism. Am J Med. 1982;73:199–204.CrossRef
10.
Zurück zum Zitat Caldis A, Broyer M, Dechaux M, Klienknect C. Primary distal tubular acidosis in childhood: clinical study and long term follow up of 28 patients. J Pediatr. 1992;121:233–41.CrossRef Caldis A, Broyer M, Dechaux M, Klienknect C. Primary distal tubular acidosis in childhood: clinical study and long term follow up of 28 patients. J Pediatr. 1992;121:233–41.CrossRef
11.
Zurück zum Zitat Disthabanchong S, Radinahamed P, Stitchantrakul W, Hongeng S, Rajatanavin R. Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. Kidney Int. 2007;71:201–9.PubMedCrossRef Disthabanchong S, Radinahamed P, Stitchantrakul W, Hongeng S, Rajatanavin R. Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. Kidney Int. 2007;71:201–9.PubMedCrossRef
12.
Zurück zum Zitat Paszkowska M, Niemir ZI, Chudek J, Czekalski S. Hypercalciuria with severe hypocalcemia in association with distal renal tubular acidosis—case report and differential diagnostics. Pol Arch Med Wewn. 2004;111:715–9.PubMed Paszkowska M, Niemir ZI, Chudek J, Czekalski S. Hypercalciuria with severe hypocalcemia in association with distal renal tubular acidosis—case report and differential diagnostics. Pol Arch Med Wewn. 2004;111:715–9.PubMed
13.
Zurück zum Zitat Tsau YK, Chen CH, Tsai WS, Chiou YM. Renal tubular acidosis in childhood. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1990;31:205–13.PubMed Tsau YK, Chen CH, Tsai WS, Chiou YM. Renal tubular acidosis in childhood. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1990;31:205–13.PubMed
14.
Zurück zum Zitat Sweid HA, Bagga A, Vaswani M, Vasudev V, Ahuja RK, Srivastava RN. Urinary excretion of minerals, oxalate and uric acid in north Indian children. Pediatr Nephrol. 1997;11:189–92.PubMedCrossRef Sweid HA, Bagga A, Vaswani M, Vasudev V, Ahuja RK, Srivastava RN. Urinary excretion of minerals, oxalate and uric acid in north Indian children. Pediatr Nephrol. 1997;11:189–92.PubMedCrossRef
15.
Zurück zum Zitat Bajpai A, Bagga A, Hari P, Bardia A, Mantan M. Long-term outcome in children with primary distal renal tubular acidosis. Indian Pediatr. 2005;42:321–8.PubMed Bajpai A, Bagga A, Hari P, Bardia A, Mantan M. Long-term outcome in children with primary distal renal tubular acidosis. Indian Pediatr. 2005;42:321–8.PubMed
16.
Zurück zum Zitat Cherqui S. Cysteamine therapy: a treatment for cystinosis, not a cure. Kidney Int. 2012;81:127–9.PubMedCrossRef Cherqui S. Cysteamine therapy: a treatment for cystinosis, not a cure. Kidney Int. 2012;81:127–9.PubMedCrossRef
17.
Zurück zum Zitat Thomas MK, Deamy MB. Vitamin D deficiency and disorders of vitamin D metabolism. Endocrinol Metab Clin N Am. 2000;29:611–27.CrossRef Thomas MK, Deamy MB. Vitamin D deficiency and disorders of vitamin D metabolism. Endocrinol Metab Clin N Am. 2000;29:611–27.CrossRef
20.
Zurück zum Zitat Santos R, Neves S, Gomes C, Neves F, Correia AJ. Rickets vitamin-D-dependent type 2. Acta Med Port. 2009;22:861–6.PubMed Santos R, Neves S, Gomes C, Neves F, Correia AJ. Rickets vitamin-D-dependent type 2. Acta Med Port. 2009;22:861–6.PubMed
21.
Zurück zum Zitat Bagga A, Sinha A. Refractory rickets. In: Shrivastava RN, Bagga A, eds. Pediatric nephrology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers; 2011. pp. 324–36.CrossRef Bagga A, Sinha A. Refractory rickets. In: Shrivastava RN, Bagga A, eds. Pediatric nephrology. 5th ed. New Delhi: Jaypee Brothers Medical Publishers; 2011. pp. 324–36.CrossRef
22.
Zurück zum Zitat Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y. A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res. 2005;58:329–33.PubMedCrossRef Cho HY, Lee BH, Kang JH, Ha IS, Cheong HI, Choi Y. A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res. 2005;58:329–33.PubMedCrossRef
23.
Zurück zum Zitat Goodver PR, Kronick JB, Jequier S, Reade TM, Scriver CR. Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr. 1987;111:700–4.CrossRef Goodver PR, Kronick JB, Jequier S, Reade TM, Scriver CR. Nephrocalcinosis and its relationship to treatment of hereditary rickets. J Pediatr. 1987;111:700–4.CrossRef
24.
Zurück zum Zitat Wesseling C, Bakkaloglu S, Salusky I. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol. 2008;23:195–207.PubMedCrossRef Wesseling C, Bakkaloglu S, Salusky I. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol. 2008;23:195–207.PubMedCrossRef
25.
Zurück zum Zitat Kobayashi A, Kawai S, Utsunomiya T, Ohbe Y. Bone disease in infants and children with hepatobiliary disease. Arch Dis Child. 1974;49:641–6.PubMedCrossRef Kobayashi A, Kawai S, Utsunomiya T, Ohbe Y. Bone disease in infants and children with hepatobiliary disease. Arch Dis Child. 1974;49:641–6.PubMedCrossRef
26.
Zurück zum Zitat Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut. 1986;27:1073–90.PubMedCrossRef Compston JE. Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease. Gut. 1986;27:1073–90.PubMedCrossRef
27.
Zurück zum Zitat Taveira AT, Pereira FA, Fernandes MI, Sawamura R, Nogueira-Barbosa MH, Paula FJ. Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease. Braz J Med Biol Res. 2010;43:1127–34.PubMedCrossRef Taveira AT, Pereira FA, Fernandes MI, Sawamura R, Nogueira-Barbosa MH, Paula FJ. Longitudinal evaluation of hepatic osteodystrophy in children and adolescents with chronic cholestatic liver disease. Braz J Med Biol Res. 2010;43:1127–34.PubMedCrossRef
Metadaten
Titel
Clinical and Etiological Profile of Refractory Rickets from Western India
verfasst von
Rajesh R. Joshi
Shailesh Patil
Sudha Rao
Publikationsdatum
01.07.2013
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 7/2013
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-012-0900-z

Weitere Artikel der Ausgabe 7/2013

Indian Journal of Pediatrics 7/2013 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.